首页> 外文会议>Conference on advances in optics for biotechnology, medicine and surgery >IMAGING OF STIFFNESS HETEROGENEITY IN PANCREATIC CANCER TO ASSESS ELASTOGRAPHY AS A SURROGATE FOR DRUG DISTRIBUTION IN ORTHOTOPIC XENOGRAFT MODELS
【24h】

IMAGING OF STIFFNESS HETEROGENEITY IN PANCREATIC CANCER TO ASSESS ELASTOGRAPHY AS A SURROGATE FOR DRUG DISTRIBUTION IN ORTHOTOPIC XENOGRAFT MODELS

机译:胰腺癌中刚度异质性的成像,评估弹性造影作为原位异种移植模型的药物分布替代品

获取原文

摘要

Limited systemic delivery in solid tumors has greatly reduced the efficacy of most therapeutic options in pancreatic ductal adenocarcinoma (PDAC). The excess of desmoplasia in PDAC tumor microenvironment elevates total tissue pressure, which is often measured via solid stress and interstitial fluid pressure. While these two factors are well-studied to characterize their influence on limited diffusion and convection transport in solid tumors, the nature of point-probe based measurements makes it difficult to assess the heterogeneous profile of tissue pressure. Therefore, this study aimed to explore tissue stiffness as an alternative biological parameter that has the potential of being a non-invasive measurement as well as having the resolution to detect tissue heterogeneity in PDAC. An ex vivo stiffness mapping system was developed which included a motorized xyz table and a fiber optic pressure sensor operated by a micro-opto-mechanical system. The motorized table tracked the spatial coordinates of the sensor as it moved along the tissue surface to independently map out stiffness at 300 micron resolution. At each location, the sensor measured pressure based on a 3-step loading test to determine stiffness. This stiffness mapping system was calibrated with ultrasound elastography to produce absolute Young's modulus values. The study has showed that stiffness heterogeneity in two orthotopic xenograft models, AsPC-1 and BxPC-3, was strongly correlated with collagen content in the tumors. The inverse correlation between stiffness and vascular patency highlighted the feasibility of using stiffness to predict drug penetration in PDAC tumors. Texture analysis to evaluate collagen thickness and structure were performed to further explore the cause of heterogeneity in pancreatic tumor microenvironment across different tumor lines.
机译:在胰腺导管腺癌(PDAC)中,固体肿瘤中最具治疗选择的功效有限的全身递送极大地降低了。 PDAC肿瘤微环境中的过量衰减升高了总组织压力,其通常通过固体应力和间质液压测量。虽然这两种因素很好地研究了它们对实体肿瘤的有限扩散和对流输送的影响,但基于点探针的测量的性质使得难以评估组织压力的异质轮廓。因此,本研究旨在探讨组织刚度作为一种替代生物参数,其具有非侵入性测量的潜力以及具有检测PDAC中的组织异质性的分辨率。开发了一个离体刚度映射系统,包括由微光机系统操作的电动XYZ台和光纤压力传感器。当沿组织表面移动时,电动台跟踪了传感器的空间坐标,以在300微米分辨率下独立地映射刚度。在每个位置,传感器基于3步加载试验测量压力以确定刚度。使用超声弹性显影校准该刚度映射系统,以产生绝对杨氏模量值。该研究表明,两个原位异种移植模型,ASPC-1和BxPC-3中的刚度异质性与肿瘤中的胶原含量强烈地相关。刚度与血管通畅之间的逆相关性突出了使用刚度预测PDAC肿瘤药物渗透的可行性。进行纹理分析,以评估胶原厚度和结构,进一步探讨不同肿瘤系胰腺肿瘤微环境中异质性的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号